<DOC>
	<DOC>NCT02261467</DOC>
	<brief_summary>This is a safety and efficacy study of onabotulinumtoxinA in subjects with forehead and glabellar facial rhytides (frown lines).</brief_summary>
	<brief_title>A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides</brief_title>
	<detailed_description />
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate to severe forehead and glabellar lines Willing to have facial photos taken Prior exposure to botulinum toxin of any serotype for any indication Anticipated need for treatment with botulinum toxin of any serotype for any indication during the study, other than study treatment Diagnosis of myasthenia gravis, EatonLambert syndrome, or amyotrophic lateral sclerosis Any facial resurfacing laser or light treatment, microdermabrasion, or superficial peels in the past 3 months Any medium depth or deep depth facial chemical peels; facial skin resurfacing; or permanent facial makeup in the past 6 months Any nonpermanent soft tissue fillers, or treatment with oral retinoids in the past year Prior face lift, thread lift, eyebrow lift, or related procedures (eg, eyelid and/or eyebrow surgery) Prior facial treatment with permanent soft tissue fillers, synthetic implants (eg, GoreTexÂ®), and/or fat transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>